Arrotex Chief Commercial Officer Hayley Tamborini said, “As Australia’s leading biosimilars provider – with the broadest biosimilars portfolio – Arrotex continues to focus on exclusive and first-to-market launches to bring increased value to community pharmacy.” …
New pharmacy-focused partnership marks the launch of two first-to-market biosimilars
August 1, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Tryp advances psilocin trial for binge eating disorder as second patient enrolled
November 18, 2025 - - Australian Biotech -
Nyrada advances toward Phase 2a trial of cardioprotective candidate
November 18, 2025 - - Australian Biotech -
We know they're planning something on these issues, because they told us
November 18, 2025 - - Latest News -
The need to honour a strong history while ensuring the future is guided by the 'good guys'
November 17, 2025 - - Latest News -
BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia
November 17, 2025 - - Latest News -
Syntara secures positive European opinion for orphan designation of amsulostat in myelofibrosis
November 17, 2025 - - Australian Biotech -
Mesoblast appoints Chief Financial Officer as it evolves into fully integrated commercial organisation
November 17, 2025 - - Australian Biotech